Zeitschriftenartikel zum Thema „3CLpro“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "3CLpro" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Ziebuhr, John, Sonja Bayer, Jeff A. Cowley und Alexander E. Gorbalenya. „The 3C-Like Proteinase of an Invertebrate Nidovirus Links Coronavirus and Potyvirus Homologs“. Journal of Virology 77, Nr. 2 (15.01.2003): 1415–26. http://dx.doi.org/10.1128/jvi.77.2.1415-1426.2003.
Der volle Inhalt der QuelleTsu, Brian V., Rimjhim Agarwal, Nandan S. Gokhale, Jessie Kulsuptrakul, Andrew P. Ryan, Elizabeth J. Fay, Lennice K. Castro et al. „Host-specific sensing of coronaviruses and picornaviruses by the CARD8 inflammasome“. PLOS Biology 21, Nr. 6 (08.06.2023): e3002144. http://dx.doi.org/10.1371/journal.pbio.3002144.
Der volle Inhalt der QuelleRawson, Jonathan M. O., Alice Duchon, Olga A. Nikolaitchik, Vinay K. Pathak und Wei-Shau Hu. „Development of a Cell-Based Luciferase Complementation Assay for Identification of SARS-CoV-2 3CLpro Inhibitors“. Viruses 13, Nr. 2 (24.01.2021): 173. http://dx.doi.org/10.3390/v13020173.
Der volle Inhalt der QuelleZhang, Jingjing, Yingpei Jiang, Chunxiu Wu, Dan Zhou, Jufang Gong, Tiejun Zhao und Zhigang Jin. „Development of FRET and Stress Granule Dual-Based System to Screen for Viral 3C Protease Inhibitors“. Molecules 28, Nr. 7 (28.03.2023): 3020. http://dx.doi.org/10.3390/molecules28073020.
Der volle Inhalt der QuelleSanachai, Kamonpan, Tuanjai Somboon, Patcharin Wilasluck, Peerapon Deetanya, Peter Wolschann, Thierry Langer, Vannajan Sanghiran Lee, Kittikhun Wangkanont, Thanyada Rungrotmongkol und Supot Hannongbua. „Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening“. PLOS ONE 17, Nr. 6 (30.06.2022): e0269563. http://dx.doi.org/10.1371/journal.pone.0269563.
Der volle Inhalt der QuelleGlab-ampai, Kittirat, Kanasap Kaewchim, Thanatsaran Saenlom, Watayagorn Thepsawat, Kodchakorn Mahasongkram, Nitat Sookrung, Wanpen Chaicumpa und Monrat Chulanetra. „Human Superantibodies to 3CLpro Inhibit Replication of SARS-CoV-2 across Variants“. International Journal of Molecular Sciences 23, Nr. 12 (13.06.2022): 6587. http://dx.doi.org/10.3390/ijms23126587.
Der volle Inhalt der QuelleYe, Gang, Xiaowei Wang, Xiaohan Tong, Yuejun Shi, Zhen F. Fu und Guiqing Peng. „Structural Basis for Inhibiting Porcine Epidemic Diarrhea Virus Replication with the 3C-Like Protease Inhibitor GC376“. Viruses 12, Nr. 2 (21.02.2020): 240. http://dx.doi.org/10.3390/v12020240.
Der volle Inhalt der QuelleChen, Chia-Nan, Coney P. C. Lin, Kuo-Kuei Huang, Wei-Cheng Chen, Hsin-Pang Hsieh, Po-Huang Liang und John T. A. Hsu. „Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3'-digallate (TF3)“. Evidence-Based Complementary and Alternative Medicine 2, Nr. 2 (2005): 209–15. http://dx.doi.org/10.1093/ecam/neh081.
Der volle Inhalt der QuelleRana, Shiwani, Prateek Kumar, Anchal Sharma, Sanjay Sharma, Rajanish Giri und Kalyan S. Ghosh. „Identification of Naturally Occurring Antiviral Molecules for SARS-CoV-2 Mitigation“. Open COVID Journal 1, Nr. 1 (10.06.2021): 38–46. http://dx.doi.org/10.2174/2666958702101010038.
Der volle Inhalt der QuelleWu, Jing, Bo Feng, Li-Xin Gao, Chun Zhang, Jia Li, Da-Jun Xiang, Yi Zang und Wen-Long Wang. „Synthesis and Biochemical Evaluation of 8H-Indeno[1,2-d]thiazole Derivatives as Novel SARS-CoV-2 3CL Protease Inhibitors“. Molecules 27, Nr. 10 (23.05.2022): 3359. http://dx.doi.org/10.3390/molecules27103359.
Der volle Inhalt der QuelleKim, Yunjeong, Vinay Shivanna, Sanjeev Narayanan, Allan M. Prior, Sahani Weerasekara, Duy H. Hua, Anushka C. Galasiti Kankanamalage, William C. Groutas und Kyeong-Ok Chang. „Broad-Spectrum Inhibitors against 3C-Like Proteases of Feline Coronaviruses and Feline Caliciviruses“. Journal of Virology 89, Nr. 9 (18.02.2015): 4942–50. http://dx.doi.org/10.1128/jvi.03688-14.
Der volle Inhalt der QuelleNaumovich, Vladislav, Maria Grishina und Vladimir Potemkin. „Establishment of models for reliability evaluation of 3CLpro ligand-receptor complexes with different binding sites“. Future Medicinal Chemistry 14, Nr. 7 (April 2022): 501–10. http://dx.doi.org/10.4155/fmc-2021-0271.
Der volle Inhalt der QuelleZhang, Yue, Huijie Chen, Mengmeng Zou, Rick Oerlemans, Changhao Shao, Yudong Ren, Ruili Zhang, Xiaodan Huang, Guangxing Li und Yingying Cong. „Hypericin Inhibit Alpha-Coronavirus Replication by Targeting 3CL Protease“. Viruses 13, Nr. 9 (14.09.2021): 1825. http://dx.doi.org/10.3390/v13091825.
Der volle Inhalt der QuelleAhmad, Bilal, Maria Batool, Qurat ul Ain, Moon Suk Kim und Sangdun Choi. „Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations“. International Journal of Molecular Sciences 22, Nr. 17 (24.08.2021): 9124. http://dx.doi.org/10.3390/ijms22179124.
Der volle Inhalt der QuelleLu, Xiao Tao, Amy C. Sims und Mark R. Denison. „Mouse Hepatitis Virus 3C-Like Protease Cleaves a 22-Kilodalton Protein from the Open Reading Frame 1a Polyprotein in Virus-Infected Cells and In Vitro“. Journal of Virology 72, Nr. 3 (01.03.1998): 2265–71. http://dx.doi.org/10.1128/jvi.72.3.2265-2271.1998.
Der volle Inhalt der QuelleIbrahim, Mahmoud A. A., Alaa H. M. Abdelrahman, Dina E. M. Mohamed, Khlood A. A. Abdeljawaad, Mohamed Ahmed Naeem, Gamal A. Gabr, Ahmed M. Shawky et al. „Chetomin, a SARS-CoV-2 3C-like Protease (3CLpro) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis“. Viruses 15, Nr. 1 (15.01.2023): 250. http://dx.doi.org/10.3390/v15010250.
Der volle Inhalt der QuelleFakih, Taufik Muhammad, und Dwi Syah Fitra Ramadhan. „Prediction of SARS-CoV-2 3C-like protease (3CLpro) crystal structure to provide COVID-19 inhibitor design through computational studies“. Biogenesis: Jurnal Ilmiah Biologi 9, Nr. 2 (30.12.2021): 213–19. http://dx.doi.org/10.24252/bio.v9i2.24520.
Der volle Inhalt der QuelleMa, Ling, Yongli Xie, Mei Zhu, Dongrong Yi, Jianyuan Zhao, Saisai Guo, Yongxin Zhang et al. „Identification of Darunavir Derivatives for Inhibition of SARS-CoV-2 3CLpro“. International Journal of Molecular Sciences 23, Nr. 24 (16.12.2022): 16011. http://dx.doi.org/10.3390/ijms232416011.
Der volle Inhalt der QuelleValipour, Mehdi, Silvia Di Giacomo, Antonella Di Sotto und Hamid Irannejad. „Discovery of Chalcone-Based Hybrid Structures as High Affinity and Site-Specific Inhibitors against SARS-CoV-2: A Comprehensive Structural Analysis Based on Various Host-Based and Viral Targets“. International Journal of Molecular Sciences 24, Nr. 10 (15.05.2023): 8789. http://dx.doi.org/10.3390/ijms24108789.
Der volle Inhalt der QuelleGuijarro-Real, Carla, Mariola Plazas, Adrián Rodríguez-Burruezo, Jaime Prohens und Ana Fita. „Potential In Vitro Inhibition of Selected Plant Extracts against SARS-CoV-2 Chymotripsin-Like Protease (3CLPro) Activity“. Foods 10, Nr. 7 (29.06.2021): 1503. http://dx.doi.org/10.3390/foods10071503.
Der volle Inhalt der QuelleJukič, Marko, Blaž Škrlj, Gašper Tomšič, Sebastian Pleško, Črtomir Podlipnik und Urban Bren. „Prioritisation of Compounds for 3CLpro Inhibitor Development on SARS-CoV-2 Variants“. Molecules 26, Nr. 10 (18.05.2021): 3003. http://dx.doi.org/10.3390/molecules26103003.
Der volle Inhalt der QuelleHuynh, Thi Ngoc Thanh, Thi Thanh Thu Tran, Thi My Hanh Pham und Kha Quang Quach. „Study on the interaction mechanism of penciclovir drug on 3CLpro of SAR-COV-2 by simulation methods“. Dong Thap University Journal of Science 12, Nr. 5 (23.06.2023): 42–47. http://dx.doi.org/10.52714/dthu.12.5.2023.1070.
Der volle Inhalt der QuelleChen, Lili, Shuai Chen, Chunshan Gui, Jianhua Shen, Xu Shen und Hualiang Jiang. „Discovering Severe Acute Respiratory Syndrome Coronavirus 3CL Protease Inhibitors: Virtual Screening, Surface Plasmon Resonance, and Fluorescence Resonance Energy Transfer Assays“. Journal of Biomolecular Screening 11, Nr. 8 (Dezember 2006): 915–21. http://dx.doi.org/10.1177/1087057106293295.
Der volle Inhalt der QuelleHamill, Pamela, Derek Hudson, Richard Y. Kao, Polly Chow, Meera Raj, Hongyan Xu, Martin J. Richer und François Jean. „Development of a red-shifted fluorescence-based assay for SARS-coronavirus 3CL protease: identification of a novel class of anti-SARS agents from the tropical marine sponge Axinella corrugata“. Biological Chemistry 387, Nr. 8 (01.08.2006): 1063–74. http://dx.doi.org/10.1515/bc.2006.131.
Der volle Inhalt der QuelleJo, Seri, Hwa Young Kim, Dong Hae Shin und Mi-Sun Kim. „Dimerization Tendency of 3CLpros of Human Coronaviruses Based on the X-ray Crystal Structure of the Catalytic Domain of SARS-CoV-2 3CLpro“. International Journal of Molecular Sciences 23, Nr. 9 (09.05.2022): 5268. http://dx.doi.org/10.3390/ijms23095268.
Der volle Inhalt der QuelleGarland, Gavin D., Robert F. Harvey, Thomas E. Mulroney, Mie Monti, Stewart Fuller, Richard Haigh, Pehuén Pereyra Gerber, Michael R. Barer, Nicholas J. Matheson und Anne E. Willis. „Development of a colorimetric assay for the detection of SARS-CoV-2 3CLpro activity“. Biochemical Journal 479, Nr. 8 (21.04.2022): 901–20. http://dx.doi.org/10.1042/bcj20220105.
Der volle Inhalt der QuelleLi, Zhonghua, Hua Cao, Yufang Cheng, Xiaoqian Zhang, Wei Zeng, Yumei Sun, Shuhua Chen, Qigai He und Heyou Han. „Inhibition of Porcine Epidemic Diarrhea Virus Replication and Viral 3C-Like Protease by Quercetin“. International Journal of Molecular Sciences 21, Nr. 21 (30.10.2020): 8095. http://dx.doi.org/10.3390/ijms21218095.
Der volle Inhalt der QuelleFitriana, Adita Silvia, und Sri Royani. „Molecular Docking Study of Chalcone Derivatives as Potential Inhibitors of SARS-CoV-2 Main Protease“. Indo. J. Chem. Res. 9, Nr. 3 (29.01.2022): 150–62. http://dx.doi.org/10.30598//ijcr.2022.9-fit.
Der volle Inhalt der QuelleHegyi, Annette, Agnes Friebe, Alexander E. Gorbalenya und John Ziebuhr. „Mutational analysis of the active centre of coronavirus 3C-like proteases“. Journal of General Virology 83, Nr. 3 (01.03.2002): 581–93. http://dx.doi.org/10.1099/0022-1317-83-3-581.
Der volle Inhalt der QuelleSaquib, Quaiser, Ahmed H. Bakheit, Sarfaraz Ahmed, Sabiha M. Ansari, Abdullah M. Al-Salem und Abdulaziz A. Al-Khedhairy. „Identification of Phytochemicals from Arabian Peninsula Medicinal Plants as Strong Binders to SARS-CoV-2 Proteases (3CLPro and PLPro) by Molecular Docking and Dynamic Simulation Studies“. Molecules 29, Nr. 5 (25.02.2024): 998. http://dx.doi.org/10.3390/molecules29050998.
Der volle Inhalt der QuelleKomissarov, Alexey, Maria Karaseva, Marina Roschina, Sergey Kostrov und Ilya Demidyuk. „The SARS-CoV-2 main protease doesn’t induce cell death in human cells in vitro“. PLOS ONE 17, Nr. 5 (24.05.2022): e0266015. http://dx.doi.org/10.1371/journal.pone.0266015.
Der volle Inhalt der QuelleZhang, Shilei, Jingfeng Wang und Genhong Cheng. „Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1“. Proceedings of the National Academy of Sciences 118, Nr. 37 (27.08.2021): e2107108118. http://dx.doi.org/10.1073/pnas.2107108118.
Der volle Inhalt der QuelleDuarte Filho, Luiz Antonio Miranda de Souza, Cintia Emi Yanaguibashi Leal, Pierre-Edouard Bodet, Edilson Beserra de Alencar Filho, Jackson Roberto Guedes da Silva Almeida, Manon Porta Zapata, Oussama Achour et al. „The Identification of Peptide Inhibitors of the Coronavirus 3CL Protease from a Fucus ceranoides L. Hydroalcoholic Extract Using a Ligand-Fishing Strategy“. Marine Drugs 22, Nr. 6 (27.05.2024): 244. http://dx.doi.org/10.3390/md22060244.
Der volle Inhalt der QuelleRajeswari, Kalepu, W. Jun Chen, A. Aashika, T. Xian Ying, C. Choon Hoong, S. Kuha und Diya Rajasekhar Chinta. „Binding Interaction Analysis of Phytoconstituents of Commiphora mukul with 3CLPro and PlPro Enzymes of SARS-CoV-2 Virus“. ECS Transactions 107, Nr. 1 (24.04.2022): 7509–30. http://dx.doi.org/10.1149/10701.7509ecst.
Der volle Inhalt der QuelleWang, Yaxin, Binghong Xu, Sen Ma, Hao Wang, Luqing Shang, Cheng Zhu und Sheng Ye. „Discovery of SARS-CoV-2 3CLPro Peptidomimetic Inhibitors through the Catalytic Dyad Histidine-Specific Protein–Ligand Interactions“. International Journal of Molecular Sciences 23, Nr. 4 (21.02.2022): 2392. http://dx.doi.org/10.3390/ijms23042392.
Der volle Inhalt der QuelleOlubiyi, Olujide O., Maryam Olagunju, Monika Keutmann, Jennifer Loschwitz und Birgit Strodel. „High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2“. Molecules 25, Nr. 14 (13.07.2020): 3193. http://dx.doi.org/10.3390/molecules25143193.
Der volle Inhalt der QuelleYang, Cheng-Wei, Yung-Ning Yang, Po-Huang Liang, Chi-Min Chen, Wei-Liang Chen, Hwan-You Chang, Yu-Sheng Chao und Shiow-Ju Lee. „Novel Small-Molecule Inhibitors of Transmissible Gastroenteritis Virus“. Antimicrobial Agents and Chemotherapy 51, Nr. 11 (20.08.2007): 3924–31. http://dx.doi.org/10.1128/aac.00408-07.
Der volle Inhalt der QuelleSobhy, Remah, Asad Nawaz, Mohammad Fikry, Rokayya Sami, Eman Algarni, Nada Benajiba, Sameer H. Qari, Alaa T. Qumsani und Ibrahim Khalifa. „In-Silico Evaluation of 10 Structurally Different Glucosinolates on the Key Enzyme of SARS-CoV-2“. Science of Advanced Materials 14, Nr. 1 (01.01.2022): 162–74. http://dx.doi.org/10.1166/sam.2022.4190.
Der volle Inhalt der QuelleDu, Weian, Liang Zhao, Rong Wu, Boning Huang, Si Liu, Yufeng Liu, Huaiqiu Huang und Ge Shi. „Predicting drug–Protein interaction with deep learning framework for molecular graphs and sequences: Potential candidates against SAR-CoV-2“. PLOS ONE 19, Nr. 5 (10.05.2024): e0299696. http://dx.doi.org/10.1371/journal.pone.0299696.
Der volle Inhalt der QuelleHaniyya, M. Ulfah, A. Riswoko, L. Mulyawati, T. Ernawati und I. Helianti. „Production of recombinant SARS-CoV-2 3CL-protease: The key for the development of protease inhibitors screening kit in search of potential herb cure for COVID-19“. IOP Conference Series: Earth and Environmental Science 976, Nr. 1 (01.02.2022): 012051. http://dx.doi.org/10.1088/1755-1315/976/1/012051.
Der volle Inhalt der QuelleZiebuhr, John, und Stuart G. Siddell. „Processing of the Human Coronavirus 229E Replicase Polyproteins by the Virus-Encoded 3C-Like Proteinase: Identification of Proteolytic Products and Cleavage Sites Common to pp1a and pp1ab“. Journal of Virology 73, Nr. 1 (01.01.1999): 177–85. http://dx.doi.org/10.1128/jvi.73.1.177-185.1999.
Der volle Inhalt der QuelleCheng, Jin, Yixuan Hao, Qin Shi, Guanyu Hou, Yanan Wang, Yong Wang, Wen Xiao et al. „Discovery of Novel Chinese Medicine Compounds Targeting 3CL Protease by Virtual Screening and Molecular Dynamics Simulation“. Molecules 28, Nr. 3 (17.01.2023): 937. http://dx.doi.org/10.3390/molecules28030937.
Der volle Inhalt der QuelleRazali, Rafida, Vijay Kumar Subbiah und Cahyo Budiman. „Technical Data of Heterologous Expression and Purification of SARS-CoV-2 Proteases Using Escherichia coli System“. Data 6, Nr. 9 (16.09.2021): 99. http://dx.doi.org/10.3390/data6090099.
Der volle Inhalt der QuelleRizzuti, Bruno, Laura Ceballos-Laita, David Ortega-Alarcon, Ana Jimenez-Alesanco, Sonia Vega, Fedora Grande, Filomena Conforti, Olga Abian und Adrian Velazquez-Campoy. „Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds“. Pharmaceuticals 14, Nr. 9 (01.09.2021): 892. http://dx.doi.org/10.3390/ph14090892.
Der volle Inhalt der QuelleMorita, Takeshi, Kei Miyakawa, Sundararaj Stanleyraj Jeremiah, Yutaro Yamaoka, Mitsuru Sada, Tomoko Kuniyoshi, Jinwei Yang, Hirokazu Kimura und Akihide Ryo. „All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity“. Viruses 13, Nr. 8 (23.08.2021): 1669. http://dx.doi.org/10.3390/v13081669.
Der volle Inhalt der QuelleAHMED, N. ZAHEER, DICKY JOHN DAVIS, NOMAN ANWAR, ASIM ALI KHAN, RAM PRATAP MEENA, ZEBA AFNAAN und MEERA DEVI. „In-Silico Evaluation of Tiryaq-E-Wabai, an Unani Formulation for its Potency against SARS-CoV-2 Spike Glycoprotein and Main Protease“. Journal of Drug Delivery and Therapeutics 11, Nr. 4-S (15.08.2021): 86–100. http://dx.doi.org/10.22270/jddt.v11i4-s.4993.
Der volle Inhalt der QuelleRizma, Baiq Ressa Puspita, Yek Zen Mubarok, Dian Fathita Dwi Lestari und Agus Dwi Ananto. „Molecular Study of Antiviral Compound of Indonesian Herbal Medicine as 3CLpro and PLpro Inhibitor in SARS-COV-2“. Acta Chimica Asiana 4, Nr. 2 (29.10.2021): 127–34. http://dx.doi.org/10.29303/aca.v4i2.74.
Der volle Inhalt der QuelleHerlah, Barbara, Andrej Hoivik, Luka Jamšek, Katja Valjavec, Norio Yamamoto, Tyuji Hoshino, Krištof Kranjc und Andrej Perdih. „Design, Synthesis and Evaluation of Fused Bicyclo[2.2.2]octene as a Potential Core Scaffold for the Non-Covalent Inhibitors of SARS-CoV-2 3CLpro Main Protease“. Pharmaceuticals 15, Nr. 5 (27.04.2022): 539. http://dx.doi.org/10.3390/ph15050539.
Der volle Inhalt der QuelleFagnani, Lorenza, Lisaurora Nazzicone, Pierangelo Bellio, Nicola Franceschini, Donatella Tondi, Andrea Verri, Sabrina Petricca et al. „Protocetraric and Salazinic Acids as Potential Inhibitors of SARS-CoV-2 3CL Protease: Biochemical, Cytotoxic, and Computational Characterization of Depsidones as Slow-Binding Inactivators“. Pharmaceuticals 15, Nr. 6 (04.06.2022): 714. http://dx.doi.org/10.3390/ph15060714.
Der volle Inhalt der QuelleMohammad, Firdous Sayeed, Mohsina F. Patwekar und Faheem I. Patwekar. „Are Plant-derived Flavonoids the Emerging Anti-coronavirus Agents?“ INNOSC Theranostics and Pharmacological Sciences 4, Nr. 2 (29.04.2022): 11–16. http://dx.doi.org/10.36922/itps.v4i2.42.
Der volle Inhalt der Quelle